| Literature DB >> 34649505 |
Wenqing Gong1, Jing Wang1, Liwei Huang2, Xu Yang3, Dingzhang Chen4, Minjuan Zheng5.
Abstract
BACKGROUND: Cervical plexus (CP) tumours are difficult to diagnose because of atypical symptoms. This study aimed to summarize the features of a normal CP and CP tumours observed on high-frequency ultrasonography.Entities:
Keywords: Cervical plexus; High-frequency ultrasonography; Tumour
Mesh:
Year: 2021 PMID: 34649505 PMCID: PMC8515767 DOI: 10.1186/s12880-021-00682-5
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 1.930
Fig. 1Normal cervical plexus and its anatomical markers. A Anatomic diagram of the CP. B Longitudinal view of the C3–C5 roots (arrows), which appear as tubular hypoechoic structures with echogenic walls and a fibrillar texture. C The C7 vertebra was used as an anatomical marker to identify the CP. Arrows point to cervical nerve C7 (transverse view, arrow) and the PT. D The bifurcation of the common carotid artery served as another anatomical marker for identifying the CP (C4 level); the arrow indicates C4. PT posterior tubercle, AT anterior tubercle, VA vertebral artery, ECA external carotid artery, ICA internal carotid artery
Measurements of normal cervical nerve roots and nerves by ultrasonography (n = 44, 22 subjects, bilateral)
| Cervical nerve | Trunk (mm) | Root (mm) | Intervertebral foramen level (mm) |
|---|---|---|---|
| Cervical plexus | |||
| C2 | 2.46 ± 0.31 | 5.03 ± 0.70 | 7.65 ± 1.36 |
| C3 | 2.75 ± 0.33 | 5.86 ± 0.82 | 9.21 ± 1.54 |
| C4 | 2.83 ± 0.39 | 6.62 ± 1.13 | 11.18 ± 7.44 |
| Mean | 2.68 ± 0.38* | 5.84 ± 1.04* | 9.35 ± 4.72* |
| Brachial plexus | |||
| C5 | 3.09 ± 0.47 | 7.33 ± 1.22 | 10.97 ± 2.55 |
| C6 | 3.48 ± 0.39 | 7.54 ± 1.72 | 11.21 ± 2.90 |
| C7 | 3.82 ± 0.55 | 7.57 ± 1.09 | 10.60 ± 2.74 |
| C8 | 3.79 ± 0.61 | 7.24 ± 1.10 | 10.40 ± 2.58 |
| Mean | 3.55 ± 0.59 | 7.42 ± 1.31 | 10.79 ± 2.68 |
*P < 0.05, compared with the mean value of the brachial plexus
Clinical and ultrasound features of cervical plexus tumours (n = 11)
| n%, mean ± SD | |
|---|---|
| Mean age (years) | 40.73 ± 13.24 |
| Female | 72.7% (8) |
| Clinical manifestation | |
| Mass | 54.5% (6) |
| Arm numbness | 27.3% (3) |
| Pressing pain | 18.2% (2) |
| High-frequency ultrasound | |
| Right side | 81.8% (9) |
| Location of mass | |
| C4 | 72.7% (8)* |
| C3 | 27.3% (3) |
| Diameter of mass (cm) | 4.83 ± 1.62 |
| Diameter of nerve trunk of the tumour (mm) | 7.49 ± 1.03 |
| Intervertebral foramen level (mm) | 12.70 ± 1.90 |
| Clear boundary with envelope integrity | 100% (11) |
| Colour Doppler grade | |
| I | 9.1% (1)* |
| II | 54.5% (6)* |
| III | 36.4% (4) |
*P < 0.05, compared with grade and with the C3 location
Fig. 2MRI, CT and contrast ultrasound images of cervical plexus schwannomas (C3 level). A 2D ultrasonography of the transverse process of the vertebra, where M is the neuroma lesion originating from the intervertebral foramen. B Colour Doppler ultrasonography showing the blood flow signal in the mass. C Contrast-enhanced ultrasound showing rich blood perfusion. D, E MRI sagittal and cross-sections of a CP mass: the arrow indicates the lesion growing outwards from the intervertebral foramen. F The arrow indicates the enlarged intervertebral foramen (3D CT reconstruction)
Fig. 3Intraoperative view and pathology of schwannoma. A Intraoperative image shows the schwannoma in the C4 CP. The blue arrow indicates the neural lesion. B HE (× 400) staining confirmed schwannoma. C, D NF and S-100 (× 400) staining demonstrating nuclear and cytoplasmic immunoreactivity
CT, MRI and Pathology diagnosis of cervical plexus tumours
| Patients | Sex | Age (years) | Mass location (intraoperative) | Pathology | US (n = 11) | CT (n= 4) | MRI (n = 11) |
|---|---|---|---|---|---|---|---|
| 1 | Male | 50 | C4 | Schwannoma | CP tumor | Masses located between the internal and external carotid arteries | Neurogenic tumor (C4 level) |
| 2 | Female | 15 | C3 | Neurofibromas | CP tumor | – | Neurogenic tumor (C3 level) |
| 3 | Female | 24 | C4 | Spindle cell tumour | Lymph nodes enlargement? CP tumor can’t be excluded | – | Lymph nodes enlargement? |
| 4 | Female | 51 | C3 | Schwannoma | CP tumor | – | Schwannoma (C3 level) |
| 5 | Female | 28 | C4 | Schwannoma | CP tumor | – | Neurogenic tumor (C3 or C4 level) |
| 6 | Female | 50 | C4 | Schwannoma | CP tumor | Carotid body tumor | Neurogenic tumor (C4 level) |
| 7 | Female | 46 | C4 | Schwannoma | CP tumor | – | Neurogenic tumor (C4 level) |
| 8 | Female | 54 | C4 | Schwannoma | CP tumor | Mass behind the Sternocleidomastoid muscle | Chemoreceptor Neoplasia |
| 9 | Female | 45 | C4 | Neurofibromas | CP tumor | Mass located in cervical plexus (C3 or C4 level) | Neurogenic tumor (C4 level) |
| 10 | Male | 51 | C3 | Schwannoma | CP tumor | – | Schwannoma (C3 or C4 level) |
| 11 | Male | 34 | C4 | Schwannoma | CP tumor | – | Lymph nodes enlargement? Neurogenic tumor can’t be excluded |
| Diagnosis sensitivity (%) | 90.90% | 25% | 72.70% | ||||
US ultrasound, CT computed tomography, MRI magnetic resonance imaging